Cover Image
市場調查報告書

歐洲的女性用植入避孕器市場

Europe Market Report for Transcervical Female Sterilization 2017 - MedCore

出版商 iData Research Inc. 商品編碼 549104
出版日期 內容資訊 英文 132 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
歐洲的女性用植入避孕器市場 Europe Market Report for Transcervical Female Sterilization 2017 - MedCore
出版日期: 2017年08月01日 內容資訊: 英文 132 Pages
簡介

本報告提供歐洲的女性用植入避孕器市場相關調查分析,提供市場分析,推動市場要素與阻礙要素,競爭分析,最近的M&A等系統性資訊。

摘要整理

歐洲的腹腔鏡設備市場:概要

競爭分析

市場趨勢

市場發展

對象市場

主要的調查更新

版本履歷

第1章 調查手法

第2章 疾病概要

  • 簡介
    • 婦產科
    • 消化管
    • 大腸

第3章 國家概況

  • 簡介
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 荷比盧三國
  • 北歐各國
  • 奧地利
  • 瑞士
  • 葡萄牙

第4章 女性用植入避孕器市場

  • 簡介
  • 市場分析與預測
  • 推動因素·阻礙因素
    • 推動市場要素
    • 市場阻礙因素
  • 競爭市場佔有率分析

簡稱

附錄

目錄
Product Code: iDATA_EULAP17_MC_TFS

Female sterilization is a permanent form of birth control, requiring invasive surgery to reverse. Female sterilization prevents ova from coming down the fallopian tubes and blocks fertilization by sperm. There are different procedures to perform female sterilization, including tubal ligation, mechanical blockage with a clip or band, bipolar electrocoagulation or transcervical implants. In this report, only the transcervical implant market is covered.

General Report Contents:

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions

The transcervical implant market in Europe currently consists of Bayer AG as the sole competitor offering the Essure® procedure. Essure® was first developed by the company Conceptus in 2001 and was certified for sale throughout Europe, with the first sale occurring in October 2002. In the United States, Essure® was subsequently approved by the FDA on November 4th, 2002. In April 2013, Bayer AG acquired Conceptus to offer Essure® as part of their contraceptive portfolio. The United Kingdom was the last country to approve the Essure® procedure in Europe, with NICE granting approval in 2009. Since the Essure® procedure entered the market in 2002, other notable competitors have been the Ovabloc System and the Adiana procedure. Both of these procedures have since been discontinued.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

EUROPE LAPAROSCOPIC DEVICE MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • 1.1. RESEARCH SCOPE
  • 1.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1. INTRODUCTION
    • 2.1.1. Gynecological Conditions
      • 2.1.1.1. Gynecological Cancers
      • 2.1.1.2. Uterine Fibroids
      • 2.1.1.3. Endometriosis
      • 2.1.1.4. Menorrhagia
      • 2.1.1.5. Pelvic Prolapse
      • 2.1.1.6. Ectopic Pregnancy
      • 2.1.1.7. Hysterectomy
    • 2.1.2. Digestive Tract Conditions
      • 2.1.2.1. Stomach Cancer
      • 2.1.2.2. Hernia
      • 2.1.2.3. Gallbladder Attack
      • 2.1.2.4. Obesity
    • 2.1.3. Colorectal Conditions
      • 2.1.3.1. Colorectal Cancer
      • 2.1.3.2. Inflammatory Bowel Disease
      • 2.1.3.3. Diverticulitis

COUNTRY PROFILES

  • 3.1. INTRODUCTION
      • 3.1.1.1. Population
      • 3.1.1.2. Median Age
      • 3.1.1.3. GDP Per Capita
      • 3.1.1.4. Price Index
  • 3.2. GERMANY
  • 3.3. FRANCE
  • 3.4. UNITED KINGDOM
  • 3.5. ITALY
  • 3.6. SPAIN
  • 3.7. BENELUX
  • 3.8. SCANDINAVIA
  • 3.9. AUSTRIA
  • 3.10. SWITZERLAND
  • 3.11. PORTUGAL

TRANSCERVICAL FEMALE STERILIZATION MARKET

  • 4.1. INTRODUCTION
    • 4.1.1. Tubal Ligation
    • 4.1.2. Mechanical Sterilization
    • 4.1.3. Bipolar Electrocoagulation
    • 4.1.4. Transcervical Implant
  • 4.2. MARKET ANALYSIS AND FORECAST
  • 4.3. DRIVERS AND LIMITERS
    • 4.3.1. Market Drivers
    • 4.3.2. Market Limiters
  • 4.4. COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

APPENDIX: COMPANY PRESS RELEASES

LIST OF CHARTS

  • Chart 1-1: Laparoscopic Devices Market by Segment, Europe, 2013 - 2023
  • Chart 1-2: Laparoscopic Devices Market Overview, Europe, 2016 & 2023
  • Chart 3-1: Country Profile, Germany, 2016
  • Chart 3-2: Country Profile, France, 2016
  • Chart 3-3: Country Profile, United Kingdom, 2016
  • Chart 3-4: Country Profile, Italy, 2016
  • Chart 3-5: Country Profile, Spain, 2016
  • Chart 3-6: Country Profile, Benelux, 2016
  • Chart 3-7: Country Profile, Scandinavia, 2016
  • Chart 3-8: Country Profile, Austria, 2016
  • Chart 3-9: Country Profile, Switzerland, 2016
  • Chart 3-10: Country Profile, Portugal, 2016
  • Chart 4-1: Transcervical Female Sterilization Market, Europe, 2013 - 2023
  • Chart 4-2: Leading Competitors, Transcervical Female Sterilization Market, Europe, 2016

LIST OF FIGURES

  • Figure 1-1: Laparoscopic Device Market Ranking by Segment, Europe, 2016 (1 of 2)
  • Figure 1-2: Laparoscopic Device Market Ranking by Segment, Europe, 2016 (2 of 2)
  • Figure 1-3: Companies Researched in this Report, Europe, 2016
  • Figure 1-4: Factors Impacting the Laparoscopic Device Market by Segment, Europe (1 of 2)
  • Figure 1-5: Factors Impacting the Laparoscopic Device Market by Segment, Europe (2 of 2)
  • Figure 1-6: Recent Events in the Laparoscopic Device Market, Europe, 2014 - 2017
  • Figure 1-7: Laparoscopic Device Markets Covered, Europe, 2016
  • Figure 1-8: Laparoscopic Device Markets Covered, Europe, 2016 (1 of 2)
  • Figure 1-9: Laparoscopic Device Markets Covered, Europe, 2016 (2 of 2)
  • Figure 1-10: Key Report Updates
  • Figure 1-11: Version History
  • Figure 4-1: Transcervical Female Sterilization Market, Europe, 2013 - 2023 (€and US$)
  • Figure 4-2: Units Sold by Country, Transcervical Female Sterilization Market, Europe, 2013-2023
  • Figure 4-3: Average Sales Price by Country, Transcervical Female Sterilization Market, Europe, 2013-2023 (€)
  • Figure 4-4: Average Sales Price by Country, Transcervical Female Sterilization Market, Europe, 2013-2023 (US$)
  • Figure 4-5: Transcervical Female Sterilization Market by Country, Europe, 2013-2023 (€M)
  • Figure 4-6: Transcervical Female Sterilization Market by Country, Europe, 2013-2023 (US$M)
  • Figure 4-7: Drivers and Limiters, Transcervical Female Sterilization Market, Europe, 2016
  • Figure 4-8: Leading Competitors by Country, Transcervical Female Sterilization Market, Europe, 2016
  • Figure 6-1: Press Release Summary
Back to Top